These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3781674)

  • 1. Single sample estimate of ethosuximide clearance.
    Bachmann K; Schwartz J; Sullivan T; Jauregui L
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):546-50. PubMed ID: 3781674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin as a probe of drug metabolism. Predicting clearance with a salivary sample.
    Bachmann K; Schwartz J; Forney R; Jauregui L
    Pharmacology; 1985; 30(3):145-52. PubMed ID: 3975264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose phenytoin clearance during erythromycin treatment.
    Bachmann K; Schwartz JI; Forney RB; Jauregui L
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):207-17. PubMed ID: 6515115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for the influence of host factors on warfarin clearance using a single dose single sample procedure.
    Bachmann K
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):167-70. PubMed ID: 3710629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism.
    Bachmann KA; Nunlee M; Martin M; Schwartz J; Jauregui L; Forney RB
    Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of single-sample clearance estimates to probe hepatic drug metabolism in rats. IV. A model for possible application to phenotyping xenobiotic influences on human drug metabolism.
    Bachmann KA
    Xenobiotica; 1989 Dec; 19(12):1449-59. PubMed ID: 2618092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I.
    Bachmann KA; Yang C; Jahn D; Schwartz J
    Xenobiotica; 1988 Feb; 18(2):151-9. PubMed ID: 3131969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethosuximide disposition kinetics in rats.
    Bachmann K; Jahn D; Yang C; Schwartz J
    Xenobiotica; 1988 Apr; 18(4):373-80. PubMed ID: 3400266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of a classical single injection 51Cr-EDTA clearance method for determination of renal function in children and adults. Part I: Analytically correct relationship between total and one-pool clearance.
    Jødal L; Brøchner-Mortensen J
    Scand J Clin Lab Invest; 2009; 69(3):305-13. PubMed ID: 19048437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].
    Perlík F; Pucelíková T; Slanar O
    Cas Lek Cesk; 2001 Feb; 140(2):51-3. PubMed ID: 11262908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis.
    Tejani A; Alexander S; Ettenger R; Lerner G; Zimmerman J; Kohaut E; Briscoe DM
    Pediatr Transplant; 2004 Apr; 8(2):151-60. PubMed ID: 15049795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid metabolism during total parenteral nutrition in healthy volunteers: evaluation of a new amino acid solution.
    Berard MP; Hankard R; Cynober L
    Clin Nutr; 2001 Oct; 20(5):407-14. PubMed ID: 11534935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of three probes to assess the influence of sex on hepatic drug metabolism.
    Bachmann KA; Schwartz J; Jauregui L; Sullivan TJ; Martin M
    Pharmacology; 1987; 35(2):88-93. PubMed ID: 3628465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.